Cassava Sciences (SAVA) News Today $14.92 +2.17 (+17.02%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 4:48 PM | marketbeat.comCassava Sciences (NASDAQ:SAVA) Shares Up 7.9%Cassava Sciences (NASDAQ:SAVA) Trading Up 7.9%July 24 at 11:42 AM | msn.comBuy Aehr Test Systems, Sell Cassava SciencesJuly 24 at 3:44 AM | seekingalpha.comCassava Sciences: Turning The Corner Into A Brick WallJuly 23, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Shares Down 4.4% Cassava Sciences (NASDAQ:SAVA) Shares Down 4.4%July 23, 2024 | benzinga.comCassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 TrialsJuly 22, 2024 | investorplace.comSAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial UpdateJuly 22, 2024 | fool.comWhy Cassava Sciences Stock Is Skyrocketing TodayJuly 21, 2024 | americanbankingnews.comCassava Sciences (NASDAQ:SAVA) Trading Up 3.5%July 20, 2024 | americanbankingnews.comCassava Sciences (NASDAQ:SAVA) Earns "Neutral" Rating from HC WainwrightJuly 19, 2024 | marketwatch.comCassava Sciences CEO, Chairman Remi Barbier ResignsJuly 19, 2024 | msn.comCassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's TrialsJuly 19, 2024 | msn.comCassava Sciences stock tumbles as CEO Remi Barbier resignsJuly 19, 2024 | nytimes.comExecutives Depart Cassava, Maker of Disputed Alzheimer’s DrugJuly 19, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Shares Up 3.5%Cassava Sciences (NASDAQ:SAVA) Stock Price Up 3.5%July 19, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Rating Reiterated by HC WainwrightHC Wainwright restated a "neutral" rating on shares of Cassava Sciences in a report on Friday.July 18, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Sees Large Volume IncreaseCassava Sciences (NASDAQ:SAVA) Sees Unusually-High Trading VolumeJuly 17, 2024 | investorplace.comSAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.July 17, 2024 | globenewswire.comCassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other InitiativesJuly 11, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Up 6.7%Cassava Sciences (NASDAQ:SAVA) Trading 6.7% HigherJuly 8, 2024 | investorplace.com3 Healthcare Stocks to Sell in July Before They Crash & BurnJuly 5, 2024 | investorplace.com3 Biotech Stocks to Sell in July Before They Crash & BurnJuly 3, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Down 2.5%Cassava Sciences (NASDAQ:SAVA) Shares Down 2.5%July 2, 2024 | seekingalpha.comCassava Sciences: A 'Moon Shot' Becomes A Bigger 'Long Shot'July 1, 2024 | seekingalpha.comCassava Sciences: Latest Blow To Simufilam Thesis As Key Former Advisor IndictedJuly 1, 2024 | fool.comWhy Cassava Sciences Stock Is Sinking TodayJuly 1, 2024 | investorplace.comSAVA Stock Alert: Former Cassava Science Advisor Charged With FraudJuly 1, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Cut to Neutral at HC WainwrightHC Wainwright downgraded Cassava Sciences from a "buy" rating to a "neutral" rating in a report on Monday.June 28, 2024 | barrons.comCassava Sciences Shares Plunge on Indictment Against Former AdvisorJune 28, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Hits New 1-Year Low at $11.00Cassava Sciences (NASDAQ:SAVA) Sets New 52-Week Low at $11.00June 28, 2024 | globenewswire.comCassava Sciences Issues Statement on Former Science AdvisorJune 27, 2024 | investorplace.comRags to Riches: 3 Biotech Stocks That Could Make Early Investors RichJune 16, 2024 | marketbeat.comCable Car Capital LLC Takes $1.20 Million Position in Cassava Sciences, Inc. (NASDAQ:SAVA)Cable Car Capital LLC acquired a new stake in Cassava Sciences, Inc. (NASDAQ:SAVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 53,500 shares of the company's stock, valueJune 6, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Stock Price Down 4.3%Cassava Sciences (NASDAQ:SAVA) Shares Down 4.3%June 4, 2024 | seekingalpha.comAll Eyes On Simufilam: Cassava Sciences' Make-Or-Break MomentMay 29, 2024 | msn.comGPT's inaccuracies in agriculture could lead to crop losses and food crisesMay 17, 2024 | benzinga.comPeering Into Cassava Sciences's Recent Short InterestMay 17, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Given New $131.00 Price Target at HC WainwrightHC Wainwright raised their target price on Cassava Sciences from $124.00 to $131.00 and gave the stock a "buy" rating in a research report on Friday.May 16, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Shares Down 6% Cassava Sciences (NASDAQ:SAVA) Shares Down 6%May 14, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Up 9.8%Cassava Sciences (NASDAQ:SAVA) Trading Up 9.8%May 10, 2024 | markets.businessinsider.comSAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024May 10, 2024 | msn.comCassava swings to Q1 profit as more patients finish simufilam phase 3 trialsMay 10, 2024 | msn.comCassava Sciences (NASDAQ:SAVA): Cracking Alzheimer’s or Succumbing to Short Sellers?May 10, 2024 | globenewswire.comCassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of SimufilamMay 10, 2024 | seekingalpha.comAnnovis, Anavex, And Cassava Sciences: Trying To Box Oneself Out Of The Alzheimer's BoxMay 8, 2024 | msn.comCassava Sciences raises over $125M from warrant distributionMay 8, 2024 | globenewswire.comCassava Sciences Announces Over $125 Million Raised from Warrant DistributionMay 7, 2024 | marketbeat.comCassava Sciences (NASDAQ:SAVA) Trading Down 6.3%Cassava Sciences (NASDAQ:SAVA) Stock Price Down 6.3%May 1, 2024 | msn.comCassava Sciences files for mixed shelf offeringMay 1, 2024 | msn.com27 Best Things to Do in San Francisco, CaliforniaMay 1, 2024 | msn.comCassava: The perilous past and promising future of a toxic but nourishing crop Get Cassava Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address NEW AI developed by trader who won 1,129% (in 2 days) (Ad)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans... Click here to see how >>> SAVA Media Mentions By Week SAVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAVA News Sentiment▼0.100.61▲Average Medical News Sentiment SAVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAVA Articles This Week▼115▲SAVA Articles Average Week Get Cassava Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Verrica Pharmaceuticals News Today Nature's Sunshine Products News Today Collegium Pharmaceutical News Today scPharmaceuticals News Today Verastem News Today Chimerix News Today Fortress Biotech News Today Janux Therapeutics News Today Amneal Pharmaceuticals News Today Maravai LifeSciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SAVA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAVA Stock Alerts